Next, we now performed in vitro killing assays with B16 melanoma cells with a customized killing assay for B16 cells by increasing the coincubation with NK cells to 24 h and the addition of IL‐15 to ensure NK cell survival over this period. This evidence concerns the gene IL15 and melanoma.